The expression of GLUT-1 and VEGF-A mRNA in the rectal cancer patients with neoadjuvant chemoradiation
Latar belakang: Angka kekambuhan dan resistensi pasien kanker rektum mencapai 40 persen. Kondisi tersebut bisa disebabkan karena peningkatan ekspresi GLUT-1 dan VEGF-A, serta mempengaruhi prognosis pasien. Tujuan penelitian ini adalah untuk mengetahui korelasi ekspresi mRNA GLUT-1 dan VEGF-A, serta...
Main Authors: | Sri Nuryani Wahyuningrum, Christina Prihharsanti, Sofia Mubarika Haryana, Ahmad Ghozali, Firly Putri Fardhila |
---|---|
Format: | Article |
Language: | English |
Published: |
Badan Penelitian dan Pengembangan Kesehatan
2020-12-01
|
Series: | Health Science Journal of Indonesia |
Subjects: | |
Online Access: | https://ejournal2.litbang.kemkes.go.id/index.php/hsji/article/view/3149 |
Similar Items
-
2-CONSERVATIVE TREATMENT OF RECTAL ADENOCARCINOMA AFTER NEOADJUVANT CHEMORADIOTHERAPY, IS IT ACCEPTABLE?
by: Majeed H Alwan
Published: (2009-06-01) -
BIOLOGICAL MARKERS OF RECTAL CANCER NEOADJUVANT CHEMORADIOTHERAPY EFFICACY
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01) -
The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis
by: Yue Zhou, et al.
Published: (2021-01-01) -
How accurate is MRI to predict response to neoadjuvant chemoradiation in locally advanced rectal cancer?
by: Afsaneh Alikhasi, et al.
Published: (2016-01-01) -
Neoadjuvant chemoradiotherapy in combined treatment of patients with rectal cancer
by: N. A. Maistrenko, et al.
Published: (2017-08-01)